Centre Hospitalier de Rochefort

Recent papers from Centre Hospitalier de Rochefort

1. Association between the site of emergency care and patient-centered outcomes in patients with cancer: rationale and design of the French COVER cohortEuropean Journal of Emergency Medicine · 2026
2. Metabolization of Flavan‐3‐ol Oligomers by Eggerthella lenta , a Human Gut BacteriumMolecular Nutrition & Food Research · 2026
3. Performance of Compound Angled Cooling Holes Within a Rotating Detonation CombustorJournal of Turbomachinery · 2026
4. The demography of an Osprey population under natural recolonisation and translocation processesIbis · 2026
5. Suicide by ligature‐strangulation with 24 rubber bands in a bathtub and self‐inflicted wounds: Biomechanical determination of fatal mechanismJournal of Forensic Sciences · 2026
6. Comparative extraction of anthraquinones from madder roots: Kinetics, selectivity and dyeing properties using maceration, ultrasound and supercritical CO₂Food and Bioproducts Processing · 2026
7. A Thin-Layer Chromatography Bioautographic Assay for the Rapid Detection of Arachidonate 5-Lipoxygenase InhibitorsAnalytica—A Journal of Analytical Chemistry and Chemical Analysis · 2026
8. 545P Real world data of capecitabine plus gemcitabine in thymic epithelial tumors: A retrospective analysisESMO Open · 2026
9. Overcoming Closed-Loop System Limits: Diluted Insulin Improves Glycemic Control and Reduces Nighttime Hypoglycemia in Toddlers with Low Insulin RequirementsDiabetes Technology & Therapeutics · 2026
10. First Insights on the Experiences, Barriers and Challenges of Remote Patient Monitoring for Chronic Heart Failure Management in a Multisite Hospital Setting in FranceHospital Topics · 2025
11. Inflammatory disorders in IDH‐mutated myeloid neoplasms: Characteristics and response to IDH inhibitorsHemaSphere · 2025
12. Outcome of patients with accelerated and blast‐phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination—A FIM studyHemaSphere · 2025
13. Risk of synchronous and second primary malignancies in multiple myeloma transplant-ineligible treated with lenalidomideBlood Advances · 2025
14. Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective study.2025
15. Assessment of Iron Deficiency Anemia in Children Aged 6–24 Months at the Follow-Up Clinic of Abia State Children's Specialist Hospital, Umuahia, Nigeria: A Cross-Sectional StudyCureus · 2025
16. Evaluating a predictive model of tyrosine kinase inhibitor therapy failure in a European-type cohort: a step towards population-specific toolsLeukemia · 2025
17. Long-term salinity exposure reveals site-specific physiological and behavioural responses in coastal and inland toadsJournal of Experimental Biology · 2025
18. A molecular signature predicts hematologic evolution in polycythemia vera patientsLeukemia · 2025
19. SplenoMegaly study (SMS): exploring the etiologies for “unexplained” splenomegalies in the real worldOrphanet Journal of Rare Diseases · 2025
20. A LEAP Forward in Wildlife Conservation: A Standardized Framework to Determine Mortality Causes in Large GPS ‐Tagged BirdsEcology and Evolution · 2025